Prometic Life Sciences Inc. announced the appointment of Stefan Clulow, Managing Director and Chief Investment Officer of Thomvest Asset Management, as Chair of Prometic's Board of Directors and Kenneth Galbraith as Chief Executive Officer.  Concurrent with these leadership changes, Professor Simon Best has been appointed Prometic's Lead Independent Director, and Dr. Benny Soffer, of Consonance, has been designated as a Prometic board observer. Professor Best's leadership as Chair and interim CEO has enabled Prometic to make its way successfully through very challenging circumstances.  Stefan Clulow is Managing Director and Chief Investment Officer of Thomvest Asset Management. Mr. Clulow has served on the Board of Prometic since 2014 and also sits on the boards of a number of private companies and charitable organizations.

Previously, Mr. Kenneth Galbraith was the Managing Director of Five Corners Capital. He joined Ventures West as a General Partner in 2007 and led the firm's biotech practice prior to founding Five Corners Capital in 2013 to continue managing the Ventures West investment portfolio. He currently serves on the Board of Directors of Macrogenics and Profound Medical.